Skip to main content

Table 1 Characteristics of guidance documents presented by geographical area

From: Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines

Guidance document Development body Publication date of current version Country and language if other than English CPG SG CP CS Rigour of development (AGREEII) % Healthcare system
Continental Europe
 Epithelial ovarian carcinoma Dutch Society for Obstetrics and Gynaecology (NVOG) 2018 Netherlands (Dutch)     66 National/Social Health Insurance
 Guideline on diagnostics, therapy and follow-up of malignant ovarian tumours The Association of Scientific Medical Societies in Germany (AWMF), led by German Society for Gynaecology and Obstetrics (DGGG) 2017 Germany (German)     81 National/Social Health Insurance
United Kingdom and Republic of Ireland
 Epithelial ovarian / fallopian tube / primary peritoneal cancer guidelines: recommendations for practice British Gynaecological Cancer Society 2017 UK     48 National Health Service
 Ovarian cancer GP referral for symptomatic women National Cancer Control Programme 2016 Republic of Ireland     7 National/Social Health Insurance
 Suspected cancer: recognition and referral National Institute for Health and Care Excellence (NICE) 2015 England, Wales, Northern Ireland     96 National Health Service
 Scottish referral guidelines for suspected cancer Healthcare Improvement Scotland 2014 Scotland     55 National Health Service
 Management of epithelial ovarian cancer Scottish Intercollegiate Guidelines Network (Part of Healthcare Improvement Scotland) 2013 Scotland     76 National Health Service
 Integrated ovarian cancer patient pathway The Danish National Health Authority 2016 Denmark (Danish)     29 National Health Service
 Ovarian cancer patient pathway The Norwegian Directorate of Health 2016 Norway (Norwegian)     38 National Health Service
 Standardised ovarian cancer care pathway a Regional Cancer Centre Co-operative Sweden 2015 Sweden (Swedish)     55 National Health Service
 Assessment of symptoms that may be ovarian cancer: a guide for general practitionersb Cancer Australia 2015 Australia     50 National/Social Health Insurance
 Appropriate referral of women with suspected ovarian cancerb Cancer Australia 2015 Australia     50 National/Social Health Insurance
 Optimal care pathway for women with ovarian cancer Cancer Council Victoria 2015 Australia     10 National/Social Health Insurance
 Suspected cancer in primary care: Guidelines for investigation, referral and reducing ethnic disparity New Zealand Guidelines Group 2009 New Zealand     56 National/Social Health Insurance
North America
 Ovarian cancer: including fallopian tube cancer and primary peritoneal cancer National Comprehensive Cancer Network 2018 (v2) USA     65 Private Health System
 The role of the obstetrician-gynaecologist in the early detection of epithelial ovarian cancer in women at average risk American College of Obstetrician Gynaecologists and the Society of Gynaecological Oncology 2017 USA     11 Private Health System
 Ovarian cancer diagnosis pathway map Cancer Care Ontario 2016 Ontario, Canada     19 National/Social Health Insurance
 Genital tract cancers in females: ovarian, fallopian tube, and primary peritoneal cancers Guidelines and Protocol Advisory Committee (Medical Services Commission) 2014 British Columbia, Canada     16 National/Social Health Insurance
  1. CPG Clinical Practice Guideline, SG Short Guideline, CP Clinical Pathway, CS Consensus Statement
  2. aA full clinical practice guideline covering initial assessment, definitive diagnosis and treatment [18], and a short version focussing on initial assessment and investigation in primary care [19], are available. Guidance on initial assessment differed slightly between the two documents. The recommendations presented in this review were extracted from the short guide. AGREEII appraisal included an assessment of the full guideline evidence review
  3. bShort guide, still active. Based on a now rescinded 2004 full clinical practice guideline entitled ‘Clinical practice guidelines for the management of women with ovarian cancer’ [20]. AGREEII appraisal included an assessment of the full guideline evidence review